Journal Mobile Options
Table of Contents
Vol. 32, No. 4, 2009
Issue release date: April 2009
Onkologie 2009;32:203–205
(DOI:10.1159/000203335)
Clinical Case · Kasuistik

Primary Renal Epithelioid Hemangioendothelioma

Karasavvidou F.a · Barbanis S.a · Gravas S.b · Ioannou M.a · Oeconomou A.b · Pappa D.a · Melekos M.D.b · Koukoulis G.a
a Department of Pathology, b Urology Clinic, University Hospital, Larissa, Greece

Abstract

Background: Epithelioid hemangioendothelioma (EH) is a rare vascular neoplasm with an unpredictable malignant potential that has been described mainly in soft tissue, liver, and lung. Case Report: We report a case of a primary renal EH in a 54-year-old woman who presented with a 3-month history of abdominal pain. Abdominal ultrasound and computed tomography scan revealed a solitary mass of 4.0 ×3.2 cm in the outer surface of the right kidney. Nephron-sparing surgery was performed. On the basis of the histological and immunohistochemical findings, the diagnosis of EH was made. The patient was free of disease 6 months after surgery. Conclusions: Although EH may have a histologically benign appearance and can be treated using a nephron-sparing approach, this neoplasm is potentially malignant urging the need for a long-term follow-up in these patients.

 goto top of outline Author Contacts

Foteini Karasavvidou, MD, Department of Pathology, University Hospital of Larissa, 411 10 Larissa, Greece, Tel. +30 24106-81794, Fax -70113, fotkarasa@yahoo.gr


 goto top of outline Article Information

Published online: March 19, 2009
Number of Print Pages : 3


 goto top of outline Publication Details

Onkologie (International Journal for Cancer Research and Treatment)

Vol. 32, No. 4, Year 2009 (Cover Date: April 2009)

Journal Editor: Schmoll H.-J. (Halle)
ISSN: 0378-584X (Print), eISSN: 1423-0240 (Online)

For additional information: http://www.karger.com/ONK


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.